Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Using historical data can significantly enhance your ability to choose index funds. Learn how to leverage this information for better investments.
26,191 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
PayPal shares surged following unconfirmed reports of a joint takeover bid by Stripe and Advent International, valued...
Moonshot AI unveils the Kimi K3 model, sparking a swift repricing in AI bets and sending chipmakers and tech names in...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A fresh national analysis finds childcare costs far outpace income growth, forcing many families to rethink childrear...
When an investment firm Absoluto Partners reveals a fresh stake in MercadoLibre, traders take note. This in-depth gui...
AI is accelerating productivity, yet the real payoff depends on how firms reallocate saved time. The resource realloc...
Institutional money is flowing back into crypto ETFs, lifting Bitcoin and other tokens. The bitcoin price prediction:...
NVIDIA signals a major pivot away from China as export controls tighten and domestic AI chip ambitions surge, a move ...
The U.S. Treasury’s latest report signals a nuanced path for crypto privacy within regulated markets, hinting at supe...
When a founder dumps stock, investors naturally pause. This article explains what the Lindblad Expeditions sell after...
Bitcoin climbs to a six-week peak near $74,000 as pepe explodes amid altcoin momentum. Major tokens follow, with ETH ...